Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method

Basic Information

ID: ALA3541093

Type: ADME

Description: Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method

Format: BAO_0000357

Organism: Homo sapiens

Target:  Cytochrome P450 2J2(ALA3491)

Document:  ALA3526101

Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method: 1

Activity Charts

Compound Summary

Parent Molecular WeightALogPPolar Surface Area
319.341.271.27
280.423.883.88
267.371.611.61
249.352.152.15
290.321.261.26
454.615.095.09
398.403.703.70
414.533.373.37
341.430.560.56
259.352.582.58
252.350.600.60
297.75-0.35-0.35
330.751.891.89
309.334.444.44
326.833.723.72
375.874.434.43
369.373.523.52
318.874.894.89
266.393.533.53
327.381.301.30
309.413.423.42
206.283.073.07
331.351.581.58
733.941.791.79
236.273.393.39
179.262.032.03
151.161.351.35
179.222.042.04
403.983.943.94
254.293.113.11
516.869.919.91
188.231.481.48
341.453.243.24
360.451.561.56
414.353.443.44
255.363.353.35
355.875.185.18
296.154.364.36
241.293.753.75
404.505.395.39
230.263.043.04
306.245.185.18
263.793.963.96
261.373.423.42
218.261.471.47
495.645.275.27
271.403.383.38
501.675.515.51
554.59-1.20-1.20
337.381.641.64
366.554.834.83
514.637.267.26
365.410.020.02
314.372.262.26
169.571.771.77
418.452.972.97
392.471.901.90
225.21-1.33-1.33
457.480.190.19
362.471.781.78
424.095.465.46
394.440.620.62
479.533.683.68
346.342.182.18
345.422.902.90
382.533.823.82
446.513.663.66
813.983.623.62
314.411.461.46